Sunday, October 4, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $333.69 +1.02%
MSFT $517.53 +0.92%
GOOGL $343.50 +1.56%
AMZN $251.52 +1.33%
TSLA $370.59 +4.65%
META $728.08 +0.30%
NVDA $233.95 +1.34%
JPM $332.38 -0.24%
BTC $37.25 -0.51%
ETH $25.46 -1.24%
AAPL
$333.69
▲ 1.02%
MSFT
$517.53
▲ 0.92%
GOOGL
$343.50
▲ 1.56%
AMZN
$251.52
▲ 1.33%
TSLA
$370.59
▲ 4.65%
META
$728.08
▲ 0.30%
NVDA
$233.95
▲ 1.34%
JPM
$332.38
▼ 0.24%
Bloomberg Markets
Attovia Therapeutics Inc., an early-stage drug developer focused on immune system diseases with high unmet need, raised $289 million in a US initial public offering that priced at the top of its marketed range.
business  Aug 5, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free